BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 29754673)

  • 1. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Ambrosy AP; Cerbin LP; DeVore AD; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Wojdyla D; Wu A; Mentz RJ
    Am Heart J; 2017 Apr; 186():130-138. PubMed ID: 28454828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
    O'Connor CM; Whellan DJ; Lee KL; Keteyian SJ; Cooper LS; Ellis SJ; Leifer ES; Kraus WE; Kitzman DW; Blumenthal JA; Rendall DS; Miller NH; Fleg JL; Schulman KA; McKelvie RS; Zannad F; Piña IL;
    JAMA; 2009 Apr; 301(14):1439-50. PubMed ID: 19351941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
    Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
    JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
    Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
    Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.
    Pandey A; Segar MW; Singh S; Reeves GR; O'Connor C; Piña I; Whellan D; Kraus WE; Mentz RJ; Kitzman DW
    Circulation; 2022 Jul; 146(2):80-90. PubMed ID: 35616018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex.
    Piña IL; Bittner V; Clare RM; Swank A; Kao A; Safford R; Nigam A; Barnard D; Walsh MN; Ellis SJ; Keteyian SJ;
    JACC Heart Fail; 2014 Apr; 2(2):180-6. PubMed ID: 24720927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
    Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
    Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.
    Luo N; O'Connor CM; Cooper LB; Sun JL; Coles A; Reed SD; Whellan DJ; Piña IL; Kraus WE; Mentz RJ
    Eur J Heart Fail; 2019 Jan; 21(1):63-70. PubMed ID: 30168635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).
    Mentz RJ; Bittner V; Schulte PJ; Fleg JL; Piña IL; Keteyian SJ; Moe G; Nigam A; Swank AM; Onwuanyi AE; Fitz-Gerald M; Kao A; Ellis SJ; Kraus WE; Whellan DJ; O'Connor CM
    Am Heart J; 2013 Sep; 166(3):488-95. PubMed ID: 24016498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.
    ; Ahmed A; Waagstein F; Pitt B; White M; Zannad F; Young JB; Rahimtoola SH
    Am J Cardiol; 2009 Jan; 103(1):82-7. PubMed ID: 19101235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
    Fiuzat M; Schulte PJ; Felker M; Ahmad T; Neely M; Adams KF; Donahue MP; Kraus WE; Piña IL; Whellan DJ; O'Connor CM
    J Card Fail; 2014 Jan; 20(1):38-44. PubMed ID: 24304938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training and pacing status in patients with heart failure: results from HF-ACTION.
    Zeitler EP; Piccini JP; Hellkamp AS; Whellan DJ; Jackson KP; Ellis SJ; Kraus WE; Keteyian SJ; Kitzman DW; Ewald GA; Fleg JL; Piña IL; O'Connor CM;
    J Card Fail; 2015 Jan; 21(1):60-7. PubMed ID: 25463413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Randomized Phase 4 Trial.
    Mudge AM; Denaro CP; Scott AC; Meyers D; Adsett JA; Mullins RW; Suna JM; Atherton JJ; Marwick TH; Scuffham P; O'Rourke P
    JACC Heart Fail; 2018 Feb; 6(2):143-152. PubMed ID: 29413370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
    Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
    Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    Luo N; Merrill P; Parikh KS; Whellan DJ; Piña IL; Fiuzat M; Kraus WE; Kitzman DW; Keteyian SJ; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Apr; 69(13):1683-1691. PubMed ID: 28359513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.